Colonization Rate and Control of Vancomycin-Resistant Enterococci in the Neonatal Intensive Care Unit / 소아감염

PURPOSE: Recently, vancomycin-resistant enterococci (VRE) have become one of the major nosocomial pathogens in Korea. However, there have been few studies on the epidemiology of VRE colonization among neonates. In this study, we investigated the prevalence of VRE colonization, risk factors for VRE, and how to control the spread of VRE infection in the Neonatal Intensive Care Unit (NICU) of Pusan National University Hospital (PNUH). METHODS: We retrospectively reviewed medical records of 192 neonates who were admitted to the NICU of PNUH from March 2006 to March 2007. Surveillance cultures from rectal swabs for detecting VRE were obtained weekly during the study period. We analyzed the prevalence of VRE and various risk factors. RESULTS: The rate of VRE colonization among NICU patients was 25% (48/192). Thirty five of these VRE colonized patients were transferred to the NICU from other local hospitals. Compared with the non-VRE group, the risk factors associated with VRE colonization were lower birth weight, congenital heart disease, applied mechanical ventilation, use of a central venous catheter, chest tubing, a history of surgery, and use of antibiotics. CONCLUSION: VRE colonization among patients admitted to the NICU is rapidly increasing. Monitoring and managing premature neonates from the beginning of the birth process, avoiding many invasive procedures, avoiding antibiotics such as vancomycin and third generation cephalosporin are important for preventing the emergence and spread of VRE colonization in the NICU.

Clinical Manifestations of Pulmonary Sequestration / 소아알레르기및호흡기학회지

PURPOSE: Pulmonary sequestration is characterized by a mass of non-functioning pulmonary tissue lacking normal communication with the tracheobronchial tree and receiving an aberrant systemic arterial blood supply. Two types have been described:intralobar and extralobar. Symptoms vary from the incidental finding of a mass to recurrent bronchitis or pneumonia, chest pain and hemoptysis. In this study, we evaluated clinical features and outcomes of pulmonary sequestration. METHODS: The records of the patients diagnosed with pulmonary sequestration by thoracic computerized tomography and aortography between January 1997 and July 2007 were retrospectively reviewed. RESULTS: Fourteen patients (6 males and 8 females) with an median age of 5.5 years in children, 35 years in adults were diagnosed with pulmonary sequestration. Nine patients had clinical symptoms including recurrent respiratory infections, chest pain and hemoptysis. Six patients were symptom free. The aberrant arteries originated from the descending thoracic aorta in 12 cases, abdominal aorta in 2 cases, inferior phrenic artery in 1 case. Thirteen patients received surgical operations with open thorax in 11 patients and with video-assisted thoracotomy surgery (VATs) in 2 cases recently diagnosed. Eleven cases (84.6%) were found to be of intralobar type and 2 cases (15.4%) were of extralobar type. One patient had bilateral pulmonary sequestration. All patients with preoperative symptoms improved after surgical treatment. CONCLUSION: The patients who presented with recurrent pneumonia in the same site, hemoptysis and chest pain should be studied to rule out pulmonary sequestration.

The effectiveness of urokinase in treatment of pleural effusion in children / 소아과

PURPOSE: Pleural effusion is a common complications of pediatric bacterial pneumonia. Intrapleural administration of fibrinolytic agents such as urokinase have been used in the management of complicated parapneumonic effusions. But the safety and effectiveness of intrapleural urokinase instillations in children has not been confirmed. The aim of this study is to evaluate the safety and effectiveness of intraperitoneal urokinase in children. METHODS: We reviewed a total of 29 children diagnosed as parapneumonic effusion with septation by chest CT or chest ultrasonography. We divided them into two groups. Fourteen children treated with urokinase after thoracostomy (Group A) were compared with 15 children treated only with thoracostomy (Group B). The urokinase, 3,000 IU/kg/day, was injected into the pleural cavity twice a day. RESULTS: There was no statistical difference in sex and age between the two groups. Total drainage volume during thoracostomy in group A and B was 375.5 mL and 350.0 mL, respectively. It was not statistically significant. But the amounts of pleural fluid of group A on day 1, day 2 and day 3 were 102.5 mL, 100.0 mL, and 70.0 mL respectively and those of group B on day 1, day 2 and say 3 were 120.0 mL, 50.0 mL and 15.0 mL respectively. To compare group A with group B in the amounts of drainage volume on day 1 was not statistically significant, but the amounts of drainage volumes on day 2 and day 3 in group A were statistically more significant than group B (Day 1 P=0.371, Day 2 P=0.049, Day 3 P=0.048, respectively). The duration of fever, antibiotics, thoracostomy and total hospital days. Were not statistically significant between the two groups. But the frequency of complications in Group A was statictically significantly lower than in group B. CONCLUSION: Intrapleural instillation of urokinase facilitates the drainage of loculated pleural effusions, especially during the first 3 days, and it could reduce complications, such as pleural thickening, surgical managements, re-positioning of tube and re-thoracostomy. So intrapleural urokinase injection was and effective and safe treatment of pleural effusion in children (P=0.014).

A Case of Laryngeal Involvement as the Sole Presenting Manifestation of Systemic Lupus Erythematosus / 대한류마티스학회지

Laryngeal involvement is a rare complication of systemic lupus erythematosus (SLE) and can range from mild mucosal inflammation, vocal cord paralysis, and edema to necrotizing vasculitis with airway obstruction. Cricoarytenoid arthropathy is rare cause of severe airway obstruction in laryngeal involvement of SLE. In contrast to patients with rheumatoid arthritis, patients with SLE typically present with acute arthritis of cricoarytenoid joints and respond to corticosteroid therapy alone. We describe here a 13-year-old girl with SLE who presented with intermittent fever, swallowing difficulty, vocal cord paralysis and acute dyspnea required emergent tracheostomy as the sole manifestation of active SLE. She was diagnosed as having SLE based on the findings of positive anti-nuclear antibody and anti-ds DNA antibody with high titers, hypocomplementemia, leukocytopenia, and transient polyarthritis and proteinuria. No other clinical symptoms were found. Endoscopic findings showed edema of aryepiglottic fold, bilateral fixation of the vocal cords and edematous supraglottic structure with engorged vessels. Computered tomography scan of the neck showed diffuse soft tissue edema around the arytenoid and cricoid cartilages and enhancement of the aryepiglottic fold.